Profile
Viridian Capital Advisors is a cannabis capital, M&A, and strategic advisory firm based in New York, NY, and Aspen, CO. Founded in 2014 by Scott Greiper, Viridian was one of the first corporate finance, M&A, advisory, and research firms in the legal cannabis and CBD industries. They have expanded into the psychedelics sector. The firm is recognized for its industry-leading research and capital markets data, aiding clients in capital raising and M&A transactions through their broker-dealer, Bradley Woods & Co. Ltd.
Viridian invests in the cannabis, CBD, and psychedelics industries, providing data-driven insights and strategic solutions for their clients. They focus on institutionalizing clients by building professional boards, creating financial models, and developing valuations and exit strategies. The firm does not disclose specific check sizes or AUM, but their Viridian Deal Tracker service provides a comprehensive analysis of market activity and trends in these sectors.
Notable transactions include strategic advisory services to leading cannabis enterprises and capital raising for medical cannabis operators in Texas. While specific portfolio companies are not disclosed, Viridian's expertise in deal tracking and capital markets intelligence positions them as a trusted adviser in their industry.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.